Weil Company’s Korro Bio KRRO Stock Holding History

Weil Company’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-203	Closed	-$357K	–	147
2020 Q4	$357K	Buy	+203	New	+$268K	0.21%	91

Other funds holding KRRO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weil Company's KRRO Position: Q1 2021 in Review

Weil Company sold out of Korro Bio (KRRO) in Q1 2021, closing a stake of 203 shares — an estimated $357K sold.

Weil Company first reported a position in KRRO in Q4 2020 and held it in 1 quarter. The position peaked at $357K in Q4 2020. 115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

Weil Company reported no remaining Korro Bio position as of Q1 2021 after selling out during the quarter.
Weil Company sold 203 Korro Bio shares in Q1 2021, an estimated $357K.
Weil Company first reported a position in Korro Bio in Q4 2020 and held it in 1 quarter.
Weil Company's Korro Bio position peaked at $357K in Q4 2020.
115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on Weil Company's 13F filing for Q1 2021, filed 12 May 2021.